Non-Small-Cell Lung Cancer

Showing 1 - 25 of 120

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)

Recruiting
  • Non-small-cell Lung Cancer
  • TQB2450 +Anlotinib+Docetaxel
  • TQB2450 +Androtinib Placebo+Docetaxel
  • Huizhou, Guangdong, China
  • +4 more
Nov 15, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

Non-small-cell Lung Cancer Trial in Rome (Fitbit charge)

Recruiting
  • Non-small-cell Lung Cancer
  • Fitbit charge
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Apr 4, 2023

Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
Jan 31, 2023

Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)

Active, not recruiting
  • Advanced Malignancies
  • Non-small-cell Lung Cancer
  • Beijing, Beijing, China
  • +51 more
Jan 11, 2023

Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

Active, not recruiting
  • Renal Cell Cancer
  • +9 more
  • PF-07263689
  • Sasanlimab
  • Duarte, California
  • +5 more
Nov 8, 2022

Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Oct 10, 2022

Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

Recruiting
  • Clear Cell Renal Cell Cancer
  • +8 more
  • La Jolla, California
  • +22 more
Aug 12, 2022

Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib (160mg))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Furmonertinib (160mg)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 2, 2022

Non-Small-Cell Lung Cancer, NSCLC Trial in Nagoya, Barcelona, Taipei (Lorlatinib)

Recruiting
  • Non-Small-Cell Lung Cancer
  • NSCLC
  • Nagoya, Aichi, Japan
  • +2 more
Jul 21, 2022

Atezolizumab in Unresectable, Locally Advanced or Metastatic

Completed
  • Non-small-Cell Lung Cancer
    • Akashi, Japan
    • +197 more
    Jul 20, 2022

    Non-Small-Cell Lung Cancer Trial in Hong Kong, Taiwan, United States (CAB-AXL-ADC, PD-1 inhibitor)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • CAB-AXL-ADC
    • PD-1 inhibitor
    • Duarte, California
    • +34 more
    Jul 11, 2022

    Cachexia, Non-Small-Cell Lung Cancer, Pancreatic Cancer Trial in United States (PF-06946860)

    Completed
    • Cachexia
    • +3 more
    • Beverly Hills, California
    • +9 more
    Jul 7, 2022

    Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Apr 20, 2022

    Non-small-cell Lung Cancer Trial (QL1706)

    Not yet recruiting
    • Non-small-cell Lung Cancer
    • (no location specified)
    Apr 7, 2022

    Non-small-cell Lung Cancer Trial (Functional Imaging of Treatment Effects)

    Completed
    • Non-small-cell Lung Cancer
    • Functional Imaging of Treatment Effects
    • (no location specified)
    Jan 28, 2022

    Non-Small-Cell Lung Cancer Trial in China (SHR-1316?Paclitaxel (Albumin Bound)?Carboplatin, SHR-1316?Chemotherapeutic,

    Recruiting
    • Non-Small-Cell Lung Cancer
    • SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin
    • +2 more
    • Beijing, Beijing, China
    • +6 more
    Oct 27, 2021

    Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib, Anlotinib)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Oct 14, 2021

    Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung

    Completed
    • Non-small-cell Lung Cancer
    • +2 more
    • DNA sequencing
    • Aalborg, Denmark
      Dept. of Oncology, Aalborg University Hospital
    Aug 3, 2021

    Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma Trial in Shanghai (SG001)

    Recruiting
    • Advanced Solid Tumours
    • +4 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Apr 29, 2021